Literature DB >> 21168770

Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter.

Masayuki Matsui1, Fuminori Sakurai, Sayda Elbashir, Donald J Foster, Muthiah Manoharan, David R Corey.   

Abstract

Low-density lipoprotein receptor (LDLR) is a cell-surface receptor that plays a central role in regulating cholesterol levels. Increased levels of LDLR would lead to reduced cholesterol levels and contribute to strategies designed to treat hypercholesterolemia. We have previously shown that duplex RNAs complementary to transcription start sites can associate with noncoding transcripts and activate gene expression. Here we show that duplex RNAs complementary to the promoter of LDLR activate expression of LDLR and increase the display of LDLR on the surface of liver cells. Activation requires complementarity to the LDLR promoter and can be achieved by chemically modified duplex RNAs. Promoter-targeted duplex RNAs can overcome repression of LDLR expression by 25-hydroxycholesterol and do not interfere with activation of LDLR expression by lovastatin. These data demonstrate that small RNAs can activate LDLR expression and affect LDLR function.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168770      PMCID: PMC3071588          DOI: 10.1016/j.chembiol.2010.10.009

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  59 in total

1.  A highly potent artificial transcription factor.

Authors:  Dusan Stanojevic; Richard A Young
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

2.  Argonaute2 is the catalytic engine of mammalian RNAi.

Authors:  Jidong Liu; Michelle A Carmell; Fabiola V Rivas; Carolyn G Marsden; J Michael Thomson; Ji-Joon Song; Scott M Hammond; Leemor Joshua-Tor; Gregory J Hannon
Journal:  Science       Date:  2004-07-29       Impact factor: 47.728

3.  Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene.

Authors:  T C Südhof; D R Van der Westhuyzen; J L Goldstein; M S Brown; D W Russell
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

4.  Small interfering RNA-induced transcriptional gene silencing in human cells.

Authors:  Kevin V Morris; Simon W-L Chan; Steven E Jacobsen; David J Looney
Journal:  Science       Date:  2004-08-05       Impact factor: 47.728

5.  Pharmacogenetic study of statin therapy and cholesterol reduction.

Authors:  Daniel I Chasman; David Posada; Lakshman Subrahmanyan; Nancy R Cook; Vincent P Stanton; Paul M Ridker
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

6.  Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity.

Authors:  Tim A Rand; Krzysztof Ginalski; Nick V Grishin; Xiaodong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

7.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

Review 8.  Overcoming the innate immune response to small interfering RNA.

Authors:  Adam Judge; Ian MacLachlan
Journal:  Hum Gene Ther       Date:  2008-02       Impact factor: 5.695

9.  Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1.

Authors:  P A Dawson; S L Hofmann; D R van der Westhuyzen; T C Südhof; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

10.  Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor.

Authors:  R D Cummings; S Kornfeld; W J Schneider; K K Hobgood; H Tolleshaug; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

View more
  44 in total

Review 1.  Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression.

Authors:  Keith T Gagnon; David R Corey
Journal:  Nucleic Acid Ther       Date:  2012-01-27       Impact factor: 5.486

2.  Upregulation of RECK gene expression by small double-stranded RNA targeting the promoter region.

Authors:  F Sakurai; Y Nanjo; S Okamoto; M Tachibana; H Mizuguchi
Journal:  Cancer Gene Ther       Date:  2014-03-21       Impact factor: 5.987

3.  Inducing gene expression by targeting promoter sequences using small activating RNAs.

Authors:  Ji Wang; Robert F Place; Victoria Portnoy; Vera Huang; Moo Rim Kang; Mika Kosaka; Maurice Kwok Chung Ho; Long-Cheng Li
Journal:  J Biol Methods       Date:  2015-03-11

4.  Autoregulation of lin-4 microRNA transcription by RNA activation (RNAa) in C. elegans.

Authors:  Michael J Turner; Alan L Jiao; Frank J Slack
Journal:  Cell Cycle       Date:  2014-01-07       Impact factor: 4.534

Review 5.  Chromatin remodeling by the small RNA machinery in mammalian cells.

Authors:  Long-Cheng Li
Journal:  Epigenetics       Date:  2013-10-22       Impact factor: 4.528

Review 6.  RNA-mediated gene activation.

Authors:  Alan L Jiao; Frank J Slack
Journal:  Epigenetics       Date:  2013-11-01       Impact factor: 4.528

Review 7.  "Clicking" Gene Therapeutics: A Successful Union of Chemistry and Biomedicine for New Solutions.

Authors:  Kira Astakhova; Roslyn Ray; Maria Taskova; Jesper Uhd; Annika Carstens; Kevin Morris
Journal:  Mol Pharm       Date:  2018-02-26       Impact factor: 4.939

Review 8.  Small RNA and transcriptional upregulation.

Authors:  Victoria Portnoy; Vera Huang; Robert F Place; Long-Cheng Li
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-05-02       Impact factor: 9.957

9.  Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding.

Authors:  Lyndi M Rice; Melissa Donigan; Muhua Yang; Weidong Liu; Devanshi Pandya; Biny K Joseph; Valerie Sodi; Tricia L Gearhart; Jenny Yip; Michael Bouchard; Joseph T Nickels
Journal:  J Biol Chem       Date:  2014-04-26       Impact factor: 5.157

10.  Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.

Authors:  Mika Kosaka; Moo Rim Kang; Glen Yang; Long-Cheng Li
Journal:  Nucleic Acid Ther       Date:  2012-08-21       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.